Mission awarded $5.2m to advance potential Parkinson’s treatment
The progressive neurodegenerative condition affects around 153,000 people in the UK
Read More
Tag: Parkinson’s UK
Parkinson’s UK awards ICL £100,000 to develop small drugs for Parkinson’s disease
The neurodegenerative condition currently affects around 153,000 people in the UK
Read More
LucyTx announces additional $12.5m research funding for neurological diseases
Alzheimer’s and Parkinson’s disease are responsible for more than 30 million cases globally
Read More
Researchers reveal people with Parkinson’s more likely to experience delirium in hospital
Two out of three people with the neurodegenerative condition experienced delirium in hospital
Read More
Parkinson’s UK grants funding of up to nearly £450,000 to four new research projects
The globally fast-growing progressive neurological condition affects around 153,000 people in the UK
Read More
Predict-PD study to identify those at high risk of PD before symptoms appear
The study aims to improve the representation of ethnic diversity within Parkinson’s research
Read More
Parkinson’s UK awards over £1.8m for nine research projects
Around 145,000 people in the UK are living with Parkinson’s disease
Read More
Parkinson’s UK grants £400,000 to research projects in Scotland
The two projects will investigate the potential causes of Parkinson’s disease
Read More
Parkinson’s UK calls on government to mark World Patient Safety Day
The report outlines ways the government can help patients with Parkinson’s disease
Read More
NRG Therapeutics gains further funding from Parkinson’s UK
Investment will be used to support the development of disease modifying drugs to treat Parkinson’s disease
Read More
Parkinson’s UK invests £1.2m in drug design project
One-year project aims to refine molecule for potential drug development
Read More
Parkinson’s UK creates Vivifi Biotech to research ‘promising’ experimental treatment
Biotech company will be dedicated to accelerating development of potential treatment
Read More
- Acoramidis approved for heart condition treatment
- Genomics study launches to optimise childhood cancer care in Ireland
- UCL researchers launch congenital muscular dystrophy research programme
- Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine
- FDA approves Click’s digital therapeutic for episodic migraine
